Wed, Sep 13, 2017
12:00 PM - 1:00 PM

Rare Disease Congressional Caucus Briefing September 13


Rare Disease Legislative Advocates in coordination with Rare Disease Congressional Caucus

Co-Chairs Representatives Leonard Lance (R-NJ) and G. K. Butterfield (D-NC) and 

Senators Orrin Hatch (R-UT) and Amy Klobuchar (D-MN) invite you to a briefing on:

Curing Rare Disease: Policy and Regulation Needed for Emerging Technology

Wednesday, September 13, 2017

12:00 – 1:00pm ET

Senate Visitors Center, Room 203-02

(Lunch will be provided.)

Moderator: Lori Sames, CEO and Founder, Hannah’s Hope Fund
  • Opening Statement 
    • Representative Leonard Lance (R-NJ) 
  • The Promise of Regenerative Medicine
    • Ralph Kern, Chief Operating Officer, Brainstorm Cell Therapeutics
    • Michael Werner, Executive Director, Alliance for Regenerative Medicine
  • Disruptive Medical Apps and Regulatory Hurdles 
    • Graham Dufault, Director of Government Affairs, ACT | The App Association
  • Regulatory Pathways for Emerging Technology 
    • Celia M. Witten, Deputy Director, the Center for Biologics Evaluation and Research (CBER), the Food and Drug Administration (FDA)
  • Closing Statement
    • Senator Amy Klobuchar (D-MN)

Event Location

Senate Visitors Center, Room 203-2
First St NE
Washington, DC 20515

The registration deadline for this event has passed.